cyclopentane has been researched along with Pulmonary Hypertension in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hao, R; Li, R; Li, X; Qian, F; Song, Y; Sun, L; Wu, Y; Yang, X; Ye, RD | 1 |
Backx, PH; Cho, HC; Gramolini, AO; He, JZ; Huang, L; Liang, W; Liu, J; Sharma, P; Ward, ME; Zhao, D | 1 |
2 other study(ies) available for cyclopentane and Pulmonary Hypertension
Article | Year |
---|---|
MLN4924 protects against interleukin-17A-induced pulmonary inflammation by disrupting ACT1-mediated signaling.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Line; Chemokine CXCL1; Cyclopentanes; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypertension, Pulmonary; Interleukin-17; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyrimidines; TNF Receptor-Associated Factor 6; Ubiquitination | 2019 |
Swelling-activated Cl- currents and intracellular CLC-3 are involved in proliferation of human pulmonary artery smooth muscle cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Cell Enlargement; Cell Proliferation; Cells, Cultured; Chloride Channels; Chlorides; Cyclopentanes; Gene Knockdown Techniques; Humans; Hypertension, Pulmonary; Immunohistochemistry; Indans; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Pulmonary Artery; Rats; RNA, Messenger; RNA, Small Interfering | 2014 |